<?xml version="1.0" ?>
<document id="95d6b47d51b17a1f41ab4df0ed64086ebc11e589">
  <chunk id="95d6b47d51b17a1f41ab4df0ed64086ebc11e589.c0" text="Open Access Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza">
    <entity charOffset="5-11" id="95d6b47d51b17a1f41ab4df0ed64086ebc11e589.c0.e0" ontology_id="CHEBI_34922" text="Access" type="chemical"/>
    <entity charOffset="94-103" id="95d6b47d51b17a1f41ab4df0ed64086ebc11e589.c0.e1" ontology_id="DOID_8469" text="influenza" type="disease"/>
    <pair e1="95d6b47d51b17a1f41ab4df0ed64086ebc11e589.c0.e0" e2="95d6b47d51b17a1f41ab4df0ed64086ebc11e589.c0.e1" id="95d6b47d51b17a1f41ab4df0ed64086ebc11e589.c0.p0" relation="true"/>
  </chunk>
  <chunk id="95d6b47d51b17a1f41ab4df0ed64086ebc11e589.c1" text="Introduction Human host immune response following infection with the new variant of A/H1N1 pandemic influenza virus (nvH1N1) is poorly understood. We utilize here systemic cytokine and antibody levels in evaluating differences in early immune response in both mild and severe patients infected with nvH1N1.">
    <entity charOffset="100-109" id="95d6b47d51b17a1f41ab4df0ed64086ebc11e589.c1.e0" ontology_id="DOID_8469" text="influenza" type="disease"/>
  </chunk>
</document>
